Gannet BioChem - Ownership and Business Overview

Life ScienceCompany

Gannet BioChem Ownership

Who owns Gannet BioChem?

Gannet BioChem is owned by Ampersand Capital Partners. It was acquired on December 2, 2024.

Is Gannet BioChem PE-backed?

Yes. Gannet BioChem is owned by private equity investor Ampersand Capital Partners.

Gannet BioChem Business Overview

Where is Gannet BioChem headquartered?

Gannet BioChem is headquartered in Huntsville, Alabama.

What sector is Gannet BioChem in?

Gannet BioChem is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Subscribe to Mergr to view all 221 acquisitions of life science companies in 2024, including 25 acquisitions by private equity firms, and 196 by strategics.

Gannet BioChem

Gannet BioChem

1112 Church Street,
Huntsville, Alabama 35801
United States,
(256) 512-9200
www.gannetbiochem.com

Gannet BioChem is a specialty CDMO specializing in the development, scaling, and manufacturing of polyethylene glycol (PEG) reagents essential components in advanced biopharmaceutical and therapeutic products. Gannet BioChem is based in Huntsville, Alabama.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Gannet BioChem

Life Science Companies